Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose for Bowel Preparation in IBD
NCT05878639Completed
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, single-blind trial of lactulose in inflammatory bowel disease (IBD) (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Effective preparation rate, Incidence of adverse events and 1 more. Started Mar 2023; status: completed.
02
Drugs
lactulose
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT05878639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05878639.